Dear Dr. Roach:I have been seeing a doctor (who is board certified) for my female patients (including women in my first cycle) for several years. He has prescribed me Finpecia, a medication used to treat thinning hair in men who have experienced hair loss. The results of his tests are that I have lost about 4-5 hairs each day. Finpecia works by preventing hair loss and preventing further hair loss, but it also has some side effects, including anemia (which is rare).
The question is, how do I know if this treatment is right for me? I have never experienced hair loss but my doctors seem to think Finpecia is better than minoxidil. It was my first line of defense when I got the first prescription for Finpecia, but when I got the second prescription, I started taking finasteride. Since then, I have been struggling with hair loss and have to use finasteride because I am pregnant and my hormones are not working well (it has been 6 months and I still have my hair).
Thanks for your detailed response!
Dr.My first reaction to Finpecia was to the fact that it is illegal to dispense it in the U. S. as a prescription drug. The FDA has not approved Finpecia (or any other prescription drug) in the U. because that is illegal in other countries. That was the only way I could get it approved for the U. and get it approved by the FDA. It is illegal to dispense Finpecia in the U. to me.
Since I am not an adult, I would be shocked by how many people have found Finpecia to be extremely effective. When I got my first prescription from my doctor, he prescribed a generic version of Finpecia. I was shocked to learn that it worked in a very similar way to Finpecia (even though I was not on the same dosage) and that it has worked for some men who have experienced hair loss.
When I started taking Finpecia, my hair loss was about 2% (although I did get my first prescription for it from a friend). It took about 6 months to see the full effects, and the difference in hair loss was not as great as it was before. The side effects were minimal, so I don’t know if they will be any worse with Finpecia (and the generic version is the same as the brand-name version).
I would like to add that I am having trouble keeping my hair. I have noticed that some women seem to lose more hair than others after using Finpecia. I have also noticed that it is a problem with my thyroid and hair is thinning. It has been a difficult time as I’m a woman and I don’t want to make it a priority for my health.
I will continue to use Finpecia as it was prescribed for me. My doctor has never prescribed Finpecia and I am not sure that I can afford it. Finpecia has been around for over 30 years and has helped millions of men (and women) with their hair loss. It is not a treatment that is easy, but I have been having to keep going for the past 6-7 years and I have been taking it for the past two years. It is definitely worth it if you are going to have a hair loss condition.
I am so happy to have been able to discuss the pros and cons of using Finpecia with my doctor. I am very concerned about my hair loss because it is not a big deal to me, but I do have some hair loss issues that I would be embarrassed to discuss. I am doing well so far but I am going to need some additional information.
Thank you in advance for your patience and guidance.
I was very surprised by the results. The Finpecia that was prescribed to me had a different effect. The first time I took my first Finpecia, I started noticing that my hair loss was about 3-5 hairs a day. I could not even see my hair from the outside. After about a month, I started losing more hair than usual. The hair growth was slow and I was having my hair fall out too much. After about a year, I noticed that my hair was thinning and began to fall out too quickly. The hair loss has been going on for more than a year and I am still having hair fall out. The only hair I have left is my eyebrows and my beard.
Finpecia (finasteride) is a medication used to treat male pattern hair loss (androgenetic alopecia). It works by blocking the enzyme 5-alpha reductase, which is responsible for converting testosterone into dihydrotestosterone (DHT). DHT is a hormone that can stimulate hair growth in men, leading to a decrease in hair growth and loss. Finpecia is a prescription medication, and is manufactured by Sun Pharmaceutical Industries. In addition to its use in treating male pattern hair loss, Finpecia is also used to treat benign prostatic hyperplasia (BPH) and prostate cancer. Finpecia is available in the strengths of 1 mg and 5 mg, which are the highest strength available. Additionally, Finpecia may be prescribed for other medical conditions, such as hormone-sensitive cancers, for example, hormone-sensitive prostate cancer, and high blood pressure. Finpecia is approved for use in patients with mild to moderate hormone-sensitive cancers, for example, hormone receptor-positive prostate cancer, for example, as adjunctive therapy for high-grade prostate cancer, and as a preventive measure against male pattern hair loss in men. It is also approved to be used in the treatment of benign prostatic hyperplasia (BPH) in men and women as adjunctive therapy for men with an enlarged prostate. Finpecia is available as an oral tablet, which is manufactured by Sun Pharmaceutical Industries. It is also available in a lower dosage of 5 mg, which is the highest strength available. It is important to note that Finpecia may cause sexual side effects such as decreased libido, erectile dysfunction, and decreased ejaculate volume. It is important to note that Finpecia is only available as an oral tablet.
VIDEOIn addition to its use in treating male pattern hair loss (androgenetic alopecia), it also may be prescribed for benign prostatic hyperplasia (BPH) and prostate cancer. Finpecia is available in a tablet form, which is made by Sun Pharmaceutical Industries. This medication is typically taken once daily, with or without food. It is important to note that Finpecia is typically used for the treatment of benign prostatic hyperplasia (BPH). It is also important to note that Finpecia is typically used to treat BPH, for example, as adjunctive therapy for men with an enlarged prostate. It is important to note that Finpecia is typically used to treat BPH, for example, as adjunctive therapy for men with an enlarged prostate.
Salt Composition in both
Salt Composition
Finasteride 1mg(same for both)
You Searched
Strip of 15 tablets
We only sell the best substitute from top brands
Our Recommendation
Finaworth 1mg Tablet 10s
Strip of 10 tablets
554+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
Yes NO- - -Apply a thin layer to affected areas and rub in a few pieces of paper. Hold the cap upright, breathe in deeply, and measure the amount of fluid in each lung. Keep the breath in your lungs, especially during wheezing. Read the form carefully and ask the doctor if the form is appropriate for your child. If not, use the form as per the doctor's instruction. The form is usually given with or without food.
Finpecia works by inhibiting the enzyme PDE5 (phosphodiesterase-5) which plays a crucial role in regulating blood flow in the body. This enzyme is responsible for inhibiting the action of the enzyme PDE5 (phosphodiesterase type 5), thereby preventing the breakdown of cGMP (cyclic guanosine monophosphate). This leads to a significant reduction of blood pressure and, consequently, to the development of a heart attack or even a stroke.
Finpecia is taken orally as a tablet. The recommended dose is one tablet once daily. The effects can last for up to 48 hours, depending on the severity of the condition being treated and the patient's condition. It is important to complete the full course of treatment as prescribed, even if symptoms improve before the medication is finished.
Finpecia is not intended to replace a doctor's advice about the appropriate use of any medication.
Finpecia is a potent medication, targeting the enzyme PDE5 (phosphodiesterase type 5), which plays a crucial role in the control of blood flow in the body. It effectively reduces the workload of the heart, effectively improving the ability to exercise and reducing the risk of blood clots.
Finpecia is specifically indicated for the treatment of male pattern hair loss (androgenetic alopecia), which is a common cause of hair loss in men. It is also prescribed to women who have a history of hereditary hair loss and wish to preserve their hair. For further information, please consult a dermatologist for medical advice.
Finpecia may cause some unwanted effects, although they are generally mild. These include dizziness, chest pain, weakness, nausea, and headache. However, these side effects are generally reversible upon discontinuation of the medication.
The most common side effects are headache, dizziness, fatigue, and sexual dysfunction. If you experience any of these symptoms, stop taking finpecia and seek medical attention immediately.
Finpecia, a potent and highly selective inhibitor of 5-alpha reductase, is a widely used drug used to treat male pattern baldness [
]. It is available as a prescription-only medication, and as a generic equivalent in many countries.
Finpecia is prescribed for the treatment of men who have male pattern hair loss (androgenic alopecia) at the crown and temples. Finpecia is also used for the treatment of benign prostatic hyperplasia, a condition characterised by enlarged prostates (
).
Finpecia is used in combination with other medicines to treat hair loss and to reduce the severity and duration of prostate cancer. It is also used to reduce the risk of developing prostate cancer.
Finpecia is indicated to be used in the treatment of male pattern baldness. It is available as an oral tablet.
The drug was initially approved for the treatment of male pattern baldness in 1997. Finpecia has been found to be effective in reducing male pattern baldness. However, there are limited clinical studies of this drug for hair loss. It is important to note that finasteride has not been studied as thoroughly in the treatment of benign prostatic hyperplasia, which is characterised by enlarged prostate.
Finpecia is not recommended for use in women, and it is not recommended for use in women with a history of or suspected of having prostate cancer. Finpecia is also not suitable for use in men who have difficulty achieving or maintaining an erection during sexual activity.
In this study, we investigated the effectiveness and safety of finasteride (
®;
) in the treatment of men with male pattern baldness, focusing on the efficacy of finasteride in reducing hair loss and prostate cancer risk. Additionally, we evaluated the safety and tolerability of the drug in patients.
A cohort study was conducted among men who were clinically diagnosed with male pattern hair loss at the dermatology unit of the Hospital Universitario Lago Di Fiori (HU). The participants were identified as those who had male pattern baldness, and who had at least a three-fold increase in hair loss over the previous two months. The participants had been taking finasteride for at least two months before the study. The study inclusion criteria included a baseline hair loss of at least three-fold, at least six months, and at least one hair loss over the previous two months.
Inclusion criteria were:
A baseline hair loss of at least three-fold, at least six months, at least one hair loss over the previous two months, and at least one hair loss over the previous three months.
Patients who had no previous history of hair loss, or were female patients, were included. Participants were recruited from a dermatology outpatient clinic for male pattern baldness at the HU. Patients were excluded if they were:
•under 18 years of age;
•a history of prostate cancer;
•a history of hair loss, or
•an active drug treatment for benign prostatic hyperplasia.
Patients were also excluded if they were aged under 18 years and had a history of hair loss.
The inclusion criteria were:
•a baseline hair loss of at least three-fold, at least six months, and at least one hair loss over the previous two months.
•a baseline hair loss of at least three-fold, at least six months, and at least one hair loss over the previous three months.
Stade de France Pharmacy